We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > 3P

News List

3P and Buzzard Pharmaceuticals Enter Cancer Collaboration contractpharma
May 08, 2021
3P Biopharmaceuticals (3P) and Buzzard Pharmaceuticals (Buzzard) have entered into a partnership agreement for manufacturing of the potent IL-I inhibitor Isunakinra, a recombinant protein for cancer indications.
3P Biopharmaceuticals Receives FDA approval contractpharma
September 19, 2019
3P Biopharmaceuticals is a contract development and manufacturing organization (CDMO) specializing in biologic process development and GMP manufacturing.
3P Biopharmaceuticals and Nordic Nanovector Extend Partnership contractpharma
June 26, 2019
For further biopharmaceutical development of Betalutin, a non-Hodgkin lymphoma (NHL) treatment.